Male patients with ER+ breast cancer tend to have grade 2 or 3 tumors, stage II or III disease, and progesterone receptor-positivity compared to female patients.

Ogletree Deakins’ T. Scott Kelly discusses the strategy of the firm’s Workforce Analytics and Compliance Practice Group, the ...

Effective maintenance of microgrids involves proactive strategies like condition-based monitoring and predictive analytics to ...

AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

The global STD testing market is set for significant growth, propelled by rising STD cases, tech innovations, and heightened public health awareness. Projected to grow from $11.03 billion in 2025 to ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

A new study using data from over 11,000 adolescents found that sleep disturbances were the most powerful predictor of future ...

The Middle East and Africa point-of-care diagnostics market is set for transformative growth, driven by rising demand for rapid and accurate diagnostic solutions. Valued at US$ 3.18 billion in 2025, ...

The proportion of patient harms associated with medical procedures, treatment, and contact with healthcare systems rose by 59 ...

Discover how digital innovation in clinical trial technology—eClinical platforms, remote data capture, and decentralized ...